| Michael David Gentile, DDS | |
|
49 Lake Ave, Suite 203, Greenwich, CT 06830-4501 | |
| (203) 869-2090 | |
| (203) 869-2535 |
| Full Name | Michael David Gentile |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 49 Lake Ave, Greenwich, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457567273 | NPI | - | NPPES |
| 008565 | Other | CT | DENTAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 008565 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael David Gentile, DDS 49 Lake Ave, Suite 203, Greenwich, CT 06830-4501 Ph: (203) 869-2090 | Michael David Gentile, DDS 49 Lake Ave, Suite 203, Greenwich, CT 06830-4501 Ph: (203) 869-2090 |
News Archive
People who rely on social media for information were more likely to be misinformed about vaccines than those who rely on traditional media, according to a study of vaccine knowledge and media use by researchers at the Annenberg Public Policy Center of the University of Pennsylvania.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
One of the problems that cancer patients face is that many of the most potent anticancer therapies can be administered only by injection, which means that cancer patients must travel to receive their medication. But thanks to a new type of nanoparticle developed by researchers at the Johns Hopkins University School of Medicine, future cancer patients may be able to receive their medication in pill form.
GE Healthcare announced today that results from its multicenter phase 2 study of flutemetamol were published in the September issue of Annals of Neurology. Flutemetamol is an investigational positron emission tomography (PET) imaging agent being developed by GE Healthcare, in the field of brain imaging.
› Verified 7 days ago
Dr. Ishrat Rangwala, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Wilbur Peck Court, Greenwich, CT 06830 Phone: 646-379-6675 Fax: 646-379-6675 | |
Dr. Randall Moore, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 141 Milbank Ave, Greenwich, CT 06830 Phone: 203-869-3377 | |
Dr. Michael Forman, D.M.D. , M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 23 Maple Ave, Greenwich, CT 06830 Phone: 203-661-5858 | |
Dr. Eman J. Traynor, D.M.D.,M.S.,L.L.C. Dentist Medicare: Not Enrolled in Medicare Practice Location: 15 Valley Dr Ste 302, Greenwich, CT 06831 Phone: 203-661-5885 Fax: 203-661-8771 | |
Dr. Joel M Leon, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 138 Milbank Ave, Greenwich, CT 06830 Phone: 203-869-8345 Fax: 203-869-0909 | |
Tiffany Madison Christensen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4 Dearfield Dr Ste 204, Greenwich, CT 06831 Phone: 203-869-2044 | |
Dr. Ashleigh Alex, DDS, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4 Dearfield Dr, Greenwich, CT 06831 Phone: 203-869-2044 |